SCHEMBL688469

SCHEMBL688469

Cc1ccc([C@H](CC(=O)O)NC(=O)Nc2cccn(Cc3ccc(F)cc3)c2=O)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 10/20 0.58
ALDH1A1 P00352 9/20 0.58
KMT2A Q03164 5/20 0.58
MEN1 O00255 4/20 0.58
HPGD P15428 3/20 0.58
CYP2C9 P11712 3/20 0.58
CYP2C19 P33261 3/20 0.58
LMNA P02545 3/20 0.57
SMN1; SMN2 Q16637 2/20 0.57
NPSR1 Q6W5P4 2/20 0.57
MAPT P10636 2/20 0.53
CYP1A2 P05177 2/20 0.53
CYP3A4 P08684 2/20 0.53
PTGER3 P43115 3/20 0.53
RAB9A P51151 2/20 0.53
TSHR P16473 1/20 0.51
ITGB1 P05556 6/20 0.49
ITGA4 P13612 6/20 0.49
MAPK1 P28482 1/20 0.48
POLB P06746 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL687856 0.92 ALDH1A1 (0.58) KDM4EALDH1A1KMT2AMEN1HPGD
SCHEMBL688126 0.90 KDM4E (0.56) KDM4EALDH1A1KMT2AMEN1HPGD
SCHEMBL688009 0.89 PTGER3 (0.58) KDM4EALDH1A1KMT2AMEN1HPGD
SCHEMBL687343 0.88 KDM4E (0.54) KDM4EALDH1A1KMT2AMEN1HPGD
SCHEMBL686797 0.88 KDM4E (0.48) KDM4EALDH1A1KMT2AMEN1HPGD
SCHEMBL688001 0.88 KDM4E (0.48) KDM4EALDH1A1KMT2AMEN1HPGD
SCHEMBL687877 0.88 ALDH1A1 (0.59) KDM4EALDH1A1KMT2AMEN1HPGD
SCHEMBL687613 0.87 PTGER3 (0.55) KDM4EALDH1A1KMT2AMEN1HPGD
SCHEMBL27568079 0.87 KDM4E (0.61) KDM4EALDH1A1KMT2AMEN1HPGD
SCHEMBL686950 0.87 KDM4E (0.61) KDM4EALDH1A1KMT2AMEN1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1203766-B1 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors ENCYSIVE PHARMACEUTICALS INC (US) 2012-02-29 EP disclosed
EP-1203766-A2 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors TEXAS BIOTECHNOLOGY CORPORATION (US) 2002-05-08 EP disclosed